DuBiotech — Dubai Biotechnology & Research Park

Overview

DuBiotech (Dubai Biotechnology and Research Park) is the UAE’s only dedicated free zone for the biotechnology and life sciences sector, established in 2005 under TECOM Group management as part of Dubai’s strategy to develop a knowledge-based economy and position the emirate as a regional centre for healthcare innovation. The zone provides a specialised environment where biotech companies, pharmaceutical researchers, clinical research organisations, and life sciences businesses can conduct research, develop products, and commercialise innovations within a regulatory framework designed for their specific needs.

The zone’s defining feature is its specialised scientific infrastructure, which includes GMP (Good Manufacturing Practice)-compliant facilities, cleanrooms, research laboratories, and analytical equipment that are simply not available in standard commercial free zones. This infrastructure reduces the capital investment required for companies to establish compliant pharmaceutical or biotech research operations in the UAE, making DuBiotech the most practical option for companies in the life sciences sector who require these capabilities.

DuBiotech operates within the broader TECOM cluster and benefits from connections to Dubai Healthcare City, Dubai Internet City, and the broader Dubai academic and healthcare ecosystem. The zone offers 100% foreign ownership, zero taxation, and full profit repatriation, with a regulatory framework that is coordinated with the UAE Ministry of Health, DHA, and other relevant regulatory bodies to ensure that life sciences companies can operate within the UAE’s comprehensive pharmaceutical and healthcare regulatory environment.

Key Benefits

DuBiotech’s specialised laboratory and GMP-compliant production infrastructure represents its most significant practical advantage. Companies requiring cleanroom environments, pharmaceutical-grade production spaces, or analytical laboratory facilities can access these at DuBiotech without the prohibitive capital cost of constructing equivalent facilities independently. For biotech startups and scale-ups, this shared infrastructure model makes UAE operations commercially viable at an earlier stage of development.

The zone’s regulatory alignment with UAE healthcare and pharmaceutical authorities is another meaningful benefit. DuBiotech companies operate within a framework that has been specifically designed for life sciences activities, with the zone authority facilitating the regulatory approvals processes that biotech and pharmaceutical companies require. This reduces the compliance burden and administrative complexity of establishing regulated scientific operations in the UAE.

Who Should Choose DuBiotech?

DuBiotech is the right choice for biotechnology companies, pharmaceutical research organisations, clinical research firms, medical device developers, genomics companies, and other life sciences businesses that require specialised laboratory and production infrastructure. It is uniquely positioned for companies whose regulatory compliance requirements go beyond what standard commercial free zones can accommodate. Service businesses and non-scientific companies should look to the broader Dubai free zone market for more appropriate and cost-effective alternatives.